BDBM163045 US9062004, 8::US9670216, 8 5-Propylamino-2-(3,3,5,5-tetramethylcyclohexyl)pyridazin-3-one

SMILES CCCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1

InChI Key InChIKey=FIDJJNCJJRGHEV-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 163045   

TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50: >1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50:  68nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50:  68nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent